Literature DB >> 25826565

It's a bit over, is that ok? The subtle surplus from tandem alternative splicing.

Karol Szafranski1, Marcel Kramer.   

Abstract

Tandem alternative splice sites (TASS) form a defined class of alternative splicing and give rise to mRNA insertion/deletion variants with only small size differences. Previous work has confirmed evolutionary conservation of TASS elements while many cases show only low tissue specificity of isoform ratios. We pinpoint stochasticity and noise as important methodological issues for the dissection of TASS isoform patterns. Resolving such uncertainties, a recent report showed regulation in a cell culture system, with shifts of alternative splicing isoform ratios dependent on cell density. This novel type of regulation affects not only multiple TASS isoforms, but also other alternative splicing classes, in a concerted manner. Here, we discuss how specific regulatory network architectures may be realized through the novel regulation type and highlight the role of differential isoform functions as a key step in order to better understand the functional role of TASS.

Keywords:  AS, alternative splicing; NAGNAG; PCAS, physiologically triggered, concerted shift in alternative splicing; TASS, tandem alternative splice sites; splice site choice; splicing factors; splicing regulation; tandem alternative splice sites

Mesh:

Substances:

Year:  2015        PMID: 25826565      PMCID: PMC4615896          DOI: 10.1080/15476286.2015.1017210

Source DB:  PubMed          Journal:  RNA Biol        ISSN: 1547-6286            Impact factor:   4.652


  42 in total

1.  The RNA splicing factor hSlu7 is required for correct 3' splice-site choice.

Authors:  K Chua; R Reed
Journal:  Nature       Date:  1999-11-11       Impact factor: 49.962

Review 2.  Influence of RNA secondary structure on the pre-mRNA splicing process.

Authors:  Emanuele Buratti; Francisco E Baralle
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

3.  Genomic splice-site analysis reveals frequent alternative splicing close to the dominant splice site.

Authors:  Yimeng Dou; Kristi L Fox-Walsh; Pierre F Baldi; Klemens J Hertel
Journal:  RNA       Date:  2006-10-19       Impact factor: 4.942

Review 4.  Spliceosome structure and function.

Authors:  Cindy L Will; Reinhard Lührmann
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

5.  Constant splice-isoform ratios in human lymphoblastoid cells support the concept of a splico-stat.

Authors:  Marcel Kramer; Klaus Huse; Uwe Menzel; Oliver Backhaus; Philip Rosenstiel; Stefan Schreiber; Jochen Hampe; Matthias Platzer
Journal:  Genetics       Date:  2011-01-10       Impact factor: 4.562

Review 6.  Gene regulatory networks and transcriptional mechanisms that control myogenesis.

Authors:  Margaret Buckingham; Peter W J Rigby
Journal:  Dev Cell       Date:  2014-02-10       Impact factor: 12.270

7.  Regulation of alternative splicing by the core spliceosomal machinery.

Authors:  Arneet L Saltzman; Qun Pan; Benjamin J Blencowe
Journal:  Genes Dev       Date:  2011-02-15       Impact factor: 11.361

Review 8.  Nature, nurture, or chance: stochastic gene expression and its consequences.

Authors:  Arjun Raj; Alexander van Oudenaarden
Journal:  Cell       Date:  2008-10-17       Impact factor: 41.582

9.  Alternative splicing at NAGNAG acceptors in Arabidopsis thaliana SR and SR-related protein-coding genes.

Authors:  Stefanie Schindler; Karol Szafranski; Michael Hiller; Gul Shad Ali; Saiprasad G Palusa; Rolf Backofen; Matthias Platzer; Anireddy S N Reddy
Journal:  BMC Genomics       Date:  2008-04-10       Impact factor: 3.969

10.  Does distance matter? Variations in alternative 3' splicing regulation.

Authors:  Martin Akerman; Yael Mandel-Gutfreund
Journal:  Nucleic Acids Res       Date:  2007-08-17       Impact factor: 16.971

View more
  1 in total

1.  Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts.

Authors:  Keren B Turton; Stephane Esnault; Larissa P Delain; Deane F Mosher
Journal:  J Vis Exp       Date:  2016-10-09       Impact factor: 1.355

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.